Kateryna Krytska

1.8k total citations
20 papers, 748 citations indexed

About

Kateryna Krytska is a scholar working on Neurology, Molecular Biology and Oncology. According to data from OpenAlex, Kateryna Krytska has authored 20 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Kateryna Krytska's work include Neuroblastoma Research and Treatments (14 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kateryna Krytska is often cited by papers focused on Neuroblastoma Research and Treatments (14 papers), Cancer therapeutics and mechanisms (8 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Kateryna Krytska collaborates with scholars based in United States, United Kingdom and Switzerland. Kateryna Krytska's co-authors include Yaël P. Mossé, Hannah T. Ryles, Renata Sano, Mark A. Lemmon, Jin H. Park, Nicole R. Infarinato, Andrew Wood, Scott C. Bresler, Eric Rappaport and Peter J. Huwe and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Cancer Research.

In The Last Decade

Kateryna Krytska

19 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kateryna Krytska United States 10 422 355 235 226 170 20 748
Idoia Martín‐Guerrero Spain 20 72 0.2× 456 1.3× 260 1.1× 269 1.2× 52 0.3× 56 1.0k
Géraldine Gouysse France 13 137 0.3× 339 1.0× 342 1.5× 134 0.6× 50 0.3× 17 829
Pavel Mazánek Czechia 12 190 0.5× 291 0.8× 105 0.4× 104 0.5× 52 0.3× 26 524
Hui‐Jen Tsai Taiwan 16 55 0.1× 130 0.4× 220 0.9× 79 0.3× 75 0.4× 53 581
Susanne Steiner Germany 13 30 0.1× 261 0.7× 246 1.0× 94 0.4× 210 1.2× 20 637
Fatao Liu China 16 28 0.1× 314 0.9× 130 0.6× 164 0.7× 90 0.5× 32 595
Shinya Osone Japan 11 111 0.3× 187 0.5× 76 0.3× 74 0.3× 46 0.3× 37 402
Elena Sabini Italy 14 68 0.2× 255 0.7× 201 0.9× 104 0.5× 87 0.5× 30 990
Kiyotaka Kawauchi Japan 15 249 0.6× 279 0.8× 156 0.7× 40 0.2× 33 0.2× 36 806
Ilaria Marinoni Switzerland 18 435 1.0× 282 0.8× 742 3.2× 115 0.5× 53 0.3× 39 1.2k

Countries citing papers authored by Kateryna Krytska

Since Specialization
Citations

This map shows the geographic impact of Kateryna Krytska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kateryna Krytska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kateryna Krytska more than expected).

Fields of papers citing papers by Kateryna Krytska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kateryna Krytska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kateryna Krytska. The network helps show where Kateryna Krytska may publish in the future.

Co-authorship network of co-authors of Kateryna Krytska

This figure shows the co-authorship network connecting the top 25 collaborators of Kateryna Krytska. A scholar is included among the top collaborators of Kateryna Krytska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kateryna Krytska. Kateryna Krytska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matkar, Smita, Michael P. East, Timothy J. Stuhlmiller, et al.. (2025). Kinome Reprogramming of G2/M Kinases and Repression of MYCN Contribute to Superior Efficacy of Lorlatinib in ALK-Driven Neuroblastoma. Molecular Cancer Therapeutics. 24(9). 1389–1401. 2 indexed citations
2.
Berko, Esther R., Arlene Naranjo, Samantha N. McNulty, et al.. (2025). Frequency and Clinical Significance of Clonal and Subclonal Driver Mutations in High-Risk Neuroblastoma at Diagnosis: A Children's Oncology Group Study. Journal of Clinical Oncology. 43(14). 1673–1684. 1 indexed citations
3.
Krytska, Kateryna, Jennifer Pogoriler, Daniel Martínez, et al.. (2022). Evaluation of the DLL3-targeting Antibody–Drug Conjugate Rovalpituzumab Tesirine in Preclinical Models of Neuroblastoma. Cancer Research Communications. 2(7). 616–623. 5 indexed citations
4.
5.
Krytska, Kateryna, Timothy L. Lochmann, Renata Sano, et al.. (2021). Venetoclax-based Rational Combinations are Effective in Models of MYCN -amplified Neuroblastoma. Molecular Cancer Therapeutics. 20(8). 1400–1411. 13 indexed citations
6.
Kurmasheva, Raushan T., Yaël P. Mossé, Eric J. Earley, et al.. (2021). Testing of B7-H3 targeting antibody-drug conjugate (ADC) MGC018 in models of pediatric solid tumors by the Pediatric Preclinical Testing Consortium (PPTC).. Journal of Clinical Oncology. 39(15_suppl). 10037–10037. 5 indexed citations
7.
Sano, Renata, Kateryna Krytska, Pichai Raman, et al.. (2019). An antibody-drug conjugate directed to the ALK receptor demonstrates efficacy in preclinical models of neuroblastoma. Science Translational Medicine. 11(483). 45 indexed citations
8.
Kurmasheva, Raushan T., E. Anders Kolb, Malcolm A. Smith, et al.. (2019). Abstract C003: Initial testing of m276-PBD CD276 antibody-drug conjugate in preclinical models of pediatric cancers by the Pediatric Preclinical Testing Consortium (PPTC). Molecular Cancer Therapeutics. 18(12_Supplement). C003–C003. 2 indexed citations
9.
Sano, Renata, Kateryna Krytska, Stephen W. Erickson, et al.. (2018). Abstract LB-136: Pediatric Preclinical Testing Consortium evaluation of a DLL3-targeted antibody drug conjugate rovalpituzumab tesirine, in neuroblastoma. Cancer Research. 78(13_Supplement). LB–136. 5 indexed citations
10.
Wood, Andrew, Kateryna Krytska, Hannah T. Ryles, et al.. (2016). Dual ALK and CDK4/6 Inhibition Demonstrates Synergy against Neuroblastoma. Clinical Cancer Research. 23(11). 2856–2868. 67 indexed citations
11.
Sano, Renata, Kateryna Krytska, Gwenda F. Ligon, et al.. (2016). Abstract 2690: A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma. Cancer Research. 76(14_Supplement). 2690–2690. 1 indexed citations
12.
Infarinato, Nicole R., Jin H. Park, Kateryna Krytska, et al.. (2015). The ALK/ROS1 Inhibitor PF-06463922 Overcomes Primary Resistance to Crizotinib in ALK-Driven Neuroblastoma. Cancer Discovery. 6(1). 96–107. 116 indexed citations
13.
Krytska, Kateryna, Hannah T. Ryles, Renata Sano, et al.. (2015). Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma. Clinical Cancer Research. 22(4). 948–960. 76 indexed citations
14.
Bresler, Scott C., Daniel A. Weiser, Peter J. Huwe, et al.. (2014). ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma. Cancer Cell. 26(5). 682–694. 252 indexed citations
15.
Bouazza, Belaïd, Kateryna Krytska, Yassine Amrani, et al.. (2012). Cytokines Alter Glucocorticoid Receptor Phosphorylation in Airway Cells. American Journal of Respiratory Cell and Molecular Biology. 47(4). 464–473. 50 indexed citations
16.
Sharma, Sunita, Omar Tliba, Kateryna Krytska, et al.. (2009). Social Stress Alters Glucocorticoid Responsiveness in a Mouse Model of Allergic Airway Inflammation. Journal of Allergy and Clinical Immunology. 123(2). S59–S59. 1 indexed citations
17.
Kierstein, S., Kateryna Krytska, Xiaoping Zhu, et al.. (2008). Surfactant protein D inhibits TNF-α production by macrophages and dendritic cells in mice. Journal of Allergy and Clinical Immunology. 122(3). 521–528. 35 indexed citations
18.
Kierstein, S., Kateryna Krytska, Yassine Amrani, et al.. (2008). Ozone inhalation induces exacerbation of eosinophilic airway inflammation and hyperresponsiveness in allergen‐sensitized mice. Allergy. 63(4). 438–446. 55 indexed citations
19.
Kierstein, S., et al.. (2008). Sugar Consumption Increases Susceptibility to Allergic Airway Inflammation and Activates the Innate Immune System in the Lung. Journal of Allergy and Clinical Immunology. 121(2). S196–S196. 15 indexed citations
20.
Kierstein, S., et al.. (2007). Regulation of Dendritic Cell Function by Surfactant Protein D. Journal of Allergy and Clinical Immunology. 119(1). S296–S296. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Idoia Martín‐Guerrero Breakdown of academic impact, for papers by Géraldine Gouysse Breakdown of academic impact, for papers by Pavel Mazánek Breakdown of academic impact, for papers by Hui‐Jen Tsai Breakdown of academic impact, for papers by Susanne Steiner Breakdown of academic impact, for papers by Fatao Liu Breakdown of academic impact, for papers by Shinya Osone Breakdown of academic impact, for papers by Elena Sabini Breakdown of academic impact, for papers by Kiyotaka Kawauchi Breakdown of academic impact, for papers by Ilaria Marinoni
Rankless by CCL
2026